V
V-Wave
Proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life
About V-Wave
V-Wave Medical is a healthcare technology startup that specializes in the development of innovative medical devices for the treatment of heart failure. Their primary product is the V-Wave Ventura Interatrial Shunt System, a breakthrough device designed to improve the quality of life for patients suffering from heart failure.
The company operates in the healthcare market, specifically targeting the cardiovascular disease segment. Their clients are primarily healthcare professionals, including doctors and nurses, who are dedicated to treating patients with heart failure. Additionally, they also serve patients, families, and loved ones who are directly affected by this disease.
V-Wave Medical's business model revolves around the research, development, and commercialization of their proprietary medical devices. They generate revenue by selling these devices to healthcare institutions and professionals. It's important to note that their main product, the Ventura Interatrial Shunt System, is currently classified as an investigational device under U.S. law, meaning it's still undergoing clinical trials.
The company is committed to advancing the flow of life by delivering breakthrough ideas and technology to the healthcare world. They are built on a foundation of science, engineering, and medicine, and are dedicated to helping patients around the globe who are living and coping with heart failure.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2009
- Headquarters
- Caesarea, Israel
- Employees
- 39
- Open positions
- None listed
- Dealroom signal
- 61.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Surgery, Cardiology and cardiovascular, Valves, Non-Invasive medical devices and treatments, Surgical Equipment, Tech for Patients, Biotech and Pharma
- Technology
- Hardware
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Aug 2024 | $600M | $600M | Johnson & Johnson | ↗ |
| SERIES COther financing | Dec 2021 | $98M | $392M | Edwards Lifesciences · BRM Capital · Israel Secondary Fund · Johnson & Johnson Innovation | ↗ |
Growth signals
Latest recorded traffic for V-Wave is 480 monthly website visits, up 380% over the last three months. V-Wave's team declined 44.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Pontifax Funds
BRM Capital
Edwards Lifesciences
TriVentures
BioStar Capital
Johnson & Johnson Innovation- PIPura Vida Investments
Series B and later6 investors entered at this stage
Deerfield
Aperture Ventures Partners
Endeavour Vision
Israel Secondary Fund
Quark Venture- APAperture Venture Partners
Other known investors1 additional known investor
Johnson & Johnson
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about V-Wave on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See V-Wave’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.